Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naveen S Basappa

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 19, 2017
Treatment options in advanced renal cell carcinoma after first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitorsNaveen S Basappa
Current Opinion in Supportive and Palliative Care|July 1, 2015
Perioperative chemotherapy for muscle invasive bladder cancerJan K Rudzinski, Naveen S Basappa, Scott North
Current Oncology (Toronto, Ont.)|September 27, 2024
Outcomes of First Subsequent Taxane Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Who Previously Received Docetaxel Intensification for Metastatic Castration-Sensitive Prostate CancerGabrielle Robin, Naveen S Basappa, Scott North, et al.
Clinical Rheumatology|February 1, 2019
Hydroxychloroquine is a safe and effective steroid-sparing agent for immune checkpoint inhibitor-induced inflammatory arthritisJanet Roberts, Michael Smylie, John Walker, et al.
Cancer|October 21, 2010
The impact of tumor burden characteristics in patients with metastatic renal cell carcinoma treated with sunitinibNaveen S Basappa, Paul Elson, Ali-Reza Golshayan, et al.
Therapeutic Advances in Medical Oncology|July 5, 2022
Evolving landscape of first-line combination therapy in advanced renal cancer: a systematic reviewAly-Khan A Lalani, Daniel Y C Heng, Naveen S Basappa, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 15, 2018
Undiagnosed cardiac deficits in non-small cell carcinoma patients in the candidate population for anti-cachexia clinical trialsSeyyed Mohammad Reza Kazemi-Bajestani, Harald Becher, Charles Butts, et al.
JACC. Case Reports|September 19, 2024
Elevated Troponin T in Immune-Checkpoint Inhibitor Myositis: A Case of Mistaken MyocarditisCarissa Beaulieu, Kai Yi Wu, Anna K Füzéry, et al.
Journal of Cachexia, Sarcopenia and Muscle|July 12, 2019
Rapid atrophy of cardiac left ventricular mass in patients with non-small cell carcinoma of the lungSeyyed Mohammad Reza Kazemi-Bajestani, Harald Becher, Charles Butts, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 1, 2019
Management algorithms for metastatic prostate cancerShawn Malone, Bobby Shayegan, Naveen S Basappa, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 19, 2017
Treatment options in advanced renal cell carcinoma after first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitorsNaveen S Basappa
Current Opinion in Supportive and Palliative Care|July 1, 2015
Perioperative chemotherapy for muscle invasive bladder cancerJan K Rudzinski, Naveen S Basappa, Scott North
Current Oncology (Toronto, Ont.)|September 27, 2024
Outcomes of First Subsequent Taxane Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Who Previously Received Docetaxel Intensification for Metastatic Castration-Sensitive Prostate CancerGabrielle Robin, Naveen S Basappa, Scott North, et al.
Clinical Rheumatology|February 1, 2019
Hydroxychloroquine is a safe and effective steroid-sparing agent for immune checkpoint inhibitor-induced inflammatory arthritisJanet Roberts, Michael Smylie, John Walker, et al.
Cancer|October 21, 2010
The impact of tumor burden characteristics in patients with metastatic renal cell carcinoma treated with sunitinibNaveen S Basappa, Paul Elson, Ali-Reza Golshayan, et al.
Therapeutic Advances in Medical Oncology|July 5, 2022
Evolving landscape of first-line combination therapy in advanced renal cancer: a systematic reviewAly-Khan A Lalani, Daniel Y C Heng, Naveen S Basappa, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 15, 2018
Undiagnosed cardiac deficits in non-small cell carcinoma patients in the candidate population for anti-cachexia clinical trialsSeyyed Mohammad Reza Kazemi-Bajestani, Harald Becher, Charles Butts, et al.
JACC. Case Reports|September 19, 2024
Elevated Troponin T in Immune-Checkpoint Inhibitor Myositis: A Case of Mistaken MyocarditisCarissa Beaulieu, Kai Yi Wu, Anna K Füzéry, et al.
Journal of Cachexia, Sarcopenia and Muscle|July 12, 2019
Rapid atrophy of cardiac left ventricular mass in patients with non-small cell carcinoma of the lungSeyyed Mohammad Reza Kazemi-Bajestani, Harald Becher, Charles Butts, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 1, 2019
Management algorithms for metastatic prostate cancerShawn Malone, Bobby Shayegan, Naveen S Basappa, et al.
Pageof 6